Cite

HARVARD Citation

    Ou, S. et al. (2016). ALK F1174V mutation confers sensitivity while ALK I1171 mutation confers resistance to alectinib. The importance of serial biopsy post progression. Lung cancer. pp. 70-72. [Online]. 
  
Back to record